GlassScriptPhysician profile
Douglas A Hutt
NPI 1457440729
$7,418.59
in general payments reported to CMS, 2019-2025
43 companies · $1,780 in 2025
The $1,780 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,385 · 2020: $354 · 2021: $334 · 2022: $1,058 · 2023: $1,243 · 2024: $1,265 · 2025: $1,780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,287.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,177.08 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $917.52 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Genzyme Corporation | $503.70 | 2019-2025 | |
| Philips North America LLC | $413.99 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und, (8874) Incourage |
| Insmed, INC. | $409.29 | 2019-2025 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $397.16 | 2019-2025 | Ofev, Spiriva Respimat, Jardiance |
| Genentech USA, INC. | $390.51 | 2019-2025 | Xolair |
| Mylan Specialty L.P. | $342.00 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $309.60 | 2019-2025 | Dupixent |
| Csl Behring | $304.46 | 2019-2025 | Hizentra |
| Novartis Pharmaceuticals Corporation | $228.91 | 2019-2025 | |
| Ani Pharmaceuticals, INC. | $204.06 | 2025 | Purified Cortrophin Gel |
| Amgen INC. | $190.71 | 2022-2025 | Tezspire |
| Grifols USA, LLC | $154.01 | 2022-2025 | Prolastin-C Liquid, Xembify |
| Viatris Specialty LLC | $153.13 | 2025 | Yupelri |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Hutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.